Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility

Rheumatology

Volumn 45, Issue 7, 2006, Pages 819-823

  Bodano A ^a   Gonzalez A ^a   Ferreiros Vidal, I ^a   Balada, E ^c   Ordi, J ^c   Carreira, P ^d   Gomez Reino J J ^a,b   Conde, Carmen ^a  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Autoantibodies; DNASEI gene; Single nucleotide polymorphism; Systemic lupus erythematosus

Indexed keywords

ARGININE; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; DEOXYRIBONUCLEASE I; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; GLUTAMINE; NUCLEOSOME ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; SINGLE STRANDED DNA;

AMINO ACID SUBSTITUTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; DEOXYRIBONUCLEASE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33745597082     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel019     Document Type: Article

References (31)

1. Tsao BP. The genetics of human systemic lupus erythematosus. Trends Immunol 2003;24:595-602.
2. Kelly JA, Moser KL, Harley JB. The genetics of systemic lupus erythematosus: Putting the pieces together. Genes Immun 2002; 3(Suppl 1):S71-85.
3. Cunninghame G, Vyse TJ. The candidate gene approach: Have murine models informed the study of human SLE? Clin Exp Immunol 2004;137:1-7.
4. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001; 15:397-408.
5. Botto M, Dell'Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56-9.
6. Bickerstaff MC, Botto M, Hutchinson WL et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 1999;5:694-7.
7. Scott RS, McMahon EJ, Pop SM et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001;411:207-11.
8. Herrmann M, Voll RE, Zoller OM et al. Impaired phagocytosis of apoptotic cells material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50.
9. Ren Y, Tang J, Mok MY, Chan AWK, Wu A, Lan CS. Increased apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003;48:2888-97.
10. Banmann I, Kolows W, Voll RE et al. Impaired uptake of apoptotic cells into tangible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002;46:191-201.
11. Ghebrehiwet B, Peerschke EI. Role of C1q and C1q receptors in the pathogenesis of systemic lupus erythematosus. Curr Dir Autoimmun 2004;7:87-97.
12. Chitrabamrung S, Rubin L, Tan EM. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1981;1:55-60.
13. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Möröy T. Features of systemic lupus erythematosus in Dnase 1-deficient mice. Nature Genet 2000;25:177-81.
14. Yasutomo K, Horiuchi T, Kagami S et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nature Genet 2001; 28:313-4.
15. Bodaño A, Amarelo J, González A, Gómez-Reino JJ, Conde C. Novel DNASE1 mutations related to systemic lupus erythematosus. Arthritis Rheum 2004;50:4070-73.
16. Shin HD, Park BL, Kim LH, Lee HS, Kim TY, Bae SC. Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum Mol Genet 2004; 13:2343-50.
17. Kishi K, Yasuda T, Takeshita H. DNase I: Structure, function, and use in medicine and forensic science. Legal Med 2001;3:69-83.
18. Yasuda T, Takeshita H, Iida R, Kogure S, Kishi K. A new allele, DNASE1*6, of human deoxyribonuclease I polymorphism encodes an Arg to Cys substitution responsible for its instability. Biochem Biophys Res Commun 1999;260:280-3.
19. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 2001;44:2446-7.
20. Macanovic M, Lachmann PJ. The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice: Studies with recombinant murine DNase and with dexamethasone. Clin Exp Immunol 1996;106:243-52.
21. Conde C, Weller S, Gilfillan S, Marcellin L, Martin T, Pasquali JL. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White) F1 mice. J Immunol 1998;161:7023-30.
22. Yasutomo K. Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus. Rheumatology 2003;42:214-22.
23. Thumboo J, Uramoto K, O'Fallon WM. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Care Res 2001;45:494-500.
24. Hudson LL, Rocca K, Song YW, Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus: A highly significant association with a determinant in the promoter region. Hum Genet 2002;111:452-5.
25. Fernandez-Blanco L, Perez-Pampin E, Gomez-Reino JJ, Gonzalez A. A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum 2004;50:328-9.
26. Suzuki A, Yamada R, Chang X et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4 are associated with rheumatoid arthritis. Nat Genet 2003;34:395-402.
27. Ikari K, Kuwahara M, Nakamura T et al. Association between PADI4 and rheumatoid arthritis. Arthritis Rheum 2005;52:3054-7.
28. Barton A, Bowes J, Eyre S et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population not associated in a United Kingdom population. Arthritis Rheum 2004;50:1117-21.
29. Kizawa H, Kou I, Iida A et al. N aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet 2005;37:138-44.
30. Mustafa Z, Dowling B, Chapman K, Sinsheimer JS, Carr A, Loughlin J. Investigating the aspartic acid (D) repeat of asporin as a risk factor for osteoarthritis in a UK Caucasian population. Arthritis Rheum 2005;52:3502-6.
31. Masuda Y, Shima G, Aiuchi T et al. Involvement of tumor necrosis factor receptor-associated protein1 (TRAP1) in apoptosis induced by β-hydroxyisovalerylshikonin. J Biol Chem 2004;279:42503-15.